Full Breakdown
Disruption of Pharmaceutical Supply Chains Amid West Asia Conflict
3/17/2026, 9:32:11 AM
Overview of the Conflict's Impact on Medicine Supply
The ongoing conflict in West Asia, primarily triggered by U.S. and Israeli attacks on Iran, has severely disrupted the flow of critical medicines to the Gulf region. This situation poses significant risks to the supply of cancer drugs and other temperature-sensitive treatments, as major air transit hubs have been compromised and shipping routes closed. Industry executives have reported that the conflict has forced companies to reroute flights and seek alternative overland access to ensure the delivery of essential medical supplies.
Key Challenges in Pharmaceutical Logistics
The conflict has led to the closure of major airports in the region, including Dubai, Abu Dhabi, and Doha, which are vital for cargo transport. These airports are crucial for the distribution of temperature-sensitive drugs, as they connect Europe with Asia and Africa. Wouter Dewulf, a professor at the Antwerp Management School, noted that over 20% of global air cargo, which includes life-saving drugs and vaccines, is now vulnerable to disruptions caused by the conflict.
Pharmaceutical companies are actively seeking alternative routes, including trucking shipments from airports in Jeddah and Riyadh, as well as considering options through Istanbul and Oman. However, establishing new "cold-chain corridors" for temperature-controlled shipments is not a quick process, and some executives have expressed concerns about the potential for significant shortages if the conflict continues.
Implications for Patient Care
Prashant Yadav, a senior fellow at the Council on Foreign Relations, highlighted that stocks of short shelf-life and temperature-sensitive medicines, particularly cancer treatments like monoclonal antibodies, are at high risk. Delays in the delivery of these medications can have severe consequences for patients, potentially forcing them to restart therapy or leading to disease progression. Some healthcare providers have warned that they could face low supplies within four to six weeks if the situation does not improve.
While some logistics providers assert that the industry is managing the current crisis, the ongoing disruptions are creating challenges. Dorothee Becher from Kuehne+Nagel stated that healthcare cargo is being prioritized, but maintaining the flow of shipments remains a constant struggle. Doaa Fathallah of Marken emphasized that cold-chain cargo is still being delivered, albeit with increased transit times and costs due to the need for round-the-clock re-routing.
Broader Supply Chain Risks
The conflict's impact extends beyond direct medicine shortages. David Weeks from Moody's pointed out that shipping disruptions could also affect the supply of essential packaging materials, such as vial stoppers and IV bag plastics. These indirect risks could further complicate the pharmaceutical supply chain, highlighting the interconnected nature of logistics in the healthcare sector.
Conclusion
As the conflict in West Asia continues, the pharmaceutical industry faces significant challenges in ensuring the timely delivery of critical medicines. While companies are currently coping with the disruptions, the potential for shortages looms if the situation persists. The ongoing reevaluation of supply routes and logistics strategies underscores the fragility of healthcare supply chains in times of geopolitical turmoil.
